Divergent immunological responses following glutaraldehyde exposure

被引:30
作者
Azadi, S [1 ]
Klink, KJ [1 ]
Meade, BJ [1 ]
机构
[1] NIOSH, Morgantown, WV 26505 USA
关键词
glutaraldehyde; dose response; Th1/Th2; response; LLNA;
D O I
10.1016/j.taap.2004.01.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although Glutaraldehyde (Glut) has been demonstrated to be a moderate contact sensitizer, numerous cases of Occupational asthma related to Glut exposure have been reported. The purpose of these Studies was to examine the close-response relationship between Glut exposure and the development of T cell-mediated vs. IgE- mediated responses. Initial evaluation of the sensitization potential was conducted using the local lymph node assay (LLNA) at concentrations ranging from 0.75% to 2.5%. A concentration-dependent increase in lymphocyte proliferation was observed with EC3 values of 0.072% and 0.089% in CBA and BALB/c mice, respectively. The mouse ear swelling test (MEST) was used to evaluate the potential for Glut to elicit IgE (1/2 h post challenge) and contact hypersensitivity (24 and 48 h post challenge) responses. An immediate response was observed in animals induced and challened with 2.5% Glut, whereas animals induced with 0.1% or 0.75% and challenged with 2.5% exhibited a delayed response 48 h post challenge. IgE-inclucing potential was evaluated by phenotypic analysis of draining lymph node cells and measurement of total serum IgE levels. Only the 2.5% exposed group demonstrated a significant increase (P < 0.01) in the percentage of IgE(+)B220(+) cells and serum IgE. Following 3 days of dermal exposure, a significant increase in IL-4 mRNA in the draining lymph nodes was observed only in the 2.5% exposed group. These results indicate that the development of an immediate vs. a delayed hypersensitivity response following dermal exposure to Glut is at least in part mediated by the exposure concentration.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 45 条
[1]   Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures [J].
Ballantyne, B ;
Jordan, SL .
JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 (02) :131-151
[2]   Overview of diisocyanate occupational asthma [J].
Bernstein, JA .
TOXICOLOGY, 1996, 111 (1-3) :181-189
[3]   INTERACTION OF ALDEHYDES WITH COLLAGEN [J].
BOWES, JH ;
CATER, CW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 168 (02) :341-&
[4]   OCCUPATIONAL RISKS OF GLUTARALDEHYDE [J].
BURGE, PS .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6695) :342-342
[5]  
Curran AD, 1996, ALLERGY, V51, P826
[6]  
Dearman RJ, 1999, CLIN EXP ALLERGY, V29, P124
[7]   Glutaraldehyde: an occupational hazard in the hospital setting [J].
Di Stefano, F ;
Siriruttanapruk, S ;
McCoach, J ;
Burge, PS .
ALLERGY, 1999, 54 (10) :1105-1109
[8]   Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease [J].
Fontenot, AP ;
Torres, M ;
Marshall, WH ;
Newman, LS ;
Kotzin, BL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12717-12722
[9]   DEVELOPMENT AND VALIDATION OF AN ALTERNATIVE DERMAL SENSITIZATION TEST - THE MOUSE EAR SWELLING TEST (MEST) [J].
GAD, SC ;
DUNN, BJ ;
DOBBS, DW ;
REILLY, C ;
WALSH, RD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 84 (01) :93-114
[10]   Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay [J].
Gerberick, GF ;
Cruse, LW ;
Ryan, CA ;
Hulette, BC ;
Chaney, JG ;
Skinner, RA ;
Dearman, RJ ;
Kimber, I .
TOXICOLOGICAL SCIENCES, 2002, 68 (02) :420-428